Morgan Stanley Initiates Coverage On West Pharmaceutical Servs with Equal-Weight Rating, Announces Price Target of $285

Benzinga · 4d ago
Morgan Stanley analyst Kallum Titchmarsh initiates coverage on West Pharmaceutical Servs (NYSE:WST) with a Equal-Weight rating and announces Price Target of $285.